Femme et Homme
- | Pays : -
- | Organes : -
- | Spécialités : -
Extrait
Assess the safety of oral single-agent crizotinib administered to patients with advanced malignancy known to have an ALK genetic event and screen for efficacy in these patients.
Critère d'inclusion
- Treatment of tumors with translocation, mutation, or amplification of the anaplastic lymphoma kinase (ALK)gene locus